Exact Sciences Corporation (EXAS) earnings
EXAS earnings moved a median of -0.07% by the close. Quarterly and annual EXAS reports and results, each read against the price at its own news timestamp. Back to the EXAS overview →
29 measured EXAS earnings events.
Where these EXAS earnings landedvs 29 measured EXAS earnings reactions
| Middle 50% of EXAS earnings reactions | -1.09% to +1.75% |
|---|---|
| Median reaction (to close) | -0.07% |
| Measured reactions | 29 |
Point-in-time · zero look-ahead
Half of the 29 EXAS earnings events with a measured close landed between -1.09% and +1.75%; 48% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-K EXACT SCIENCES CORP For: Dec 31 | SEC filing · Form 10-K | -0.01% | +0.11% | |
| Exact Sciences Announces Third Quarter 2025 Results | Press release | -1.11% | -0.70% | |
| Form 10-Q EXACT SCIENCES CORP For: Sep 30 | SEC filing · Form 10-Q | -1.11% | -0.70% | |
| Exact Sciences Schedules Third Quarter 2025 Earnings Call | Press release | +0.27% | +1.75% | |
| Exact Sciences Announces Second Quarter 2025 Results | Press release | +5.86% | +10.67% | |
| Form 10-Q EXACT SCIENCES CORP For: Jun 30 | SEC filing · Form 10-Q | +5.86% | +10.67% | |
| Exact Sciences Schedules Second Quarter 2025 Earnings Call | Press release | +0.95% | +5.68% | |
| Exact Sciences Announces First-Quarter 2025 Results | Press release | +0.33% | -1.09% | |
| Form 10-Q EXACT SCIENCES CORP For: Mar 31 | SEC filing · Form 10-Q | +0.33% | -1.09% | |
| Exact Sciences Schedules First Quarter 2025 Earnings Call | Press release | -0.54% | +0.07% | |
| Exact Sciences Announces Fourth Quarter 2024 Results | Press release | -2.88% | +3.15% | |
| Form 10-K EXACT SCIENCES CORP For: Dec 31 | SEC filing · Form 10-K | -2.88% | +3.15% | |
| Exact Sciences Schedules Fourth Quarter 2024 Earnings Call | Press release | -0.36% | +0.77% | |
| Exact Sciences Announces Preliminary Fourth Quarter 2024 Results | Press release | -0.72% | -0.07% | |
| Exact Sciences Announces Third-Quarter 2024 Results | Press release | -5.23% | -0.62% | |
| Form 10-Q EXACT SCIENCES CORP For: Sep 30 | SEC filing · Form 10-Q | -5.23% | -0.62% | |
| Exact Sciences Schedules Third Quarter 2024 Earnings Call | Press release | -0.14% | -1.14% | |
| Exact Sciences Announces Second-Quarter 2024 Results | Press release | -1.37% | +4.85% | |
| Form 10-Q EXACT SCIENCES CORP For: Jun 30 | SEC filing · Form 10-Q | -1.37% | +4.85% | |
| Exact Sciences schedules second quarter 2024 earnings call | Press release | +0.54% | +1.46% | |
| Exact Sciences Announces First-Quarter 2024 Results | Press release | -0.57% | -0.64% | |
| Form 10-Q EXACT SCIENCES CORP For: Mar 31 | SEC filing · Form 10-Q | -0.57% | -0.64% | |
| Exact Sciences Schedules First Quarter 2024 Earnings Call | Press release | +0.70% | +1.57% | |
| Exact Sciences Announces Fourth Quarter 2023 Results | Press release | +2.11% | -3.28% | |
| Form 10-K EXACT SCIENCES CORP For: Dec 31 | SEC filing · Form 10-K | +2.11% | -3.28% | |
| Exact Sciences Schedules Fourth Quarter 2023 Earnings Call | Press release | +0.16% | -3.87% | |
| Exact Sciences Announces Preliminary Fourth Quarter 2023 Results | Press release | -2.13% | +0.10% | |
| Exact Sciences Announces Third-Quarter 2023 Results | Press release | +3.82% | -1.09% | |
| Form 10-Q EXACT SCIENCES CORP For: Sep 30 | SEC filing · Form 10-Q | +3.82% | -1.09% |
Keep exploring
More EXAS: analyst actions → · SEC filings → · EXAS overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| KalVista Pharmaceuticals, Inc. (KALV) | 438 | 0.00% | 50% |
| Zymeworks Inc. (ZYME) | 438 | 0.00% | 50% |
| IMMUNE PHARMACEUTICALS INC NE (IMNP) | 437 | -0.77% | 36% |
| Intec Pharma Ltd (NTEC) | 437 | -0.26% | 36% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.